Stephens Consulting, LLC Adma Biologics, Inc. Transaction History
Stephens Consulting, LLC
- $400 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
322Shares Held
190MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$311 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$302 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$217 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$210 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$143 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.27B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...